← FDA Drug Approvals (Drugs@FDA)

LEVOTHYROXINE SODIUM

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: XIROMED · Approved 2024-11-29

Drug application

FDA Application #

ANDA217495

Application type

Abbreviated New Drug Application (Generic)

Brand name

LEVOTHYROXINE SODIUM

Generic name

Levothyroxine Sodium

Active ingredients

LEVOTHYROXINE SODIUM

Dosage form

POWDER

Route

INTRAVENOUS

Marketing status

Prescription

Sponsor

XIROMED

First approval

2024-11-29

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown